Medicine
Olanzapine 20 mg tablet
Olanzapine 20 mg tablet is a generic prescription medicine for oral use, made by 19 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store olanzapine tablets at controlled room temperature, 20° to 25°C (68° to…
Key facts
- Active ingredient (INN)
- Olanzapine
- Brand
- Sold under the generic name
- Strength
- 20 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 1000 tablets, 30 tablets and 52 more
- Manufacturers
- Ascend LaboratoriesIndiaAurobindo PharmaIndiaDr. Reddy's LaboratoriesIndiaMacleods PharmaceuticalsIndiaTorrent PharmaceuticalsIndiaCadila PharmaceuticalsIndiaModavar PharmaceuticalsApotexCouplerHEC Pharm19 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store olanzapine tablets at controlled room temperature, 20° to 25°C (68° to 77°F). The USP defines controlled room temperature as a temperature maintained thermostatically that encompasses the usual and customary working environment of 20° to 25°C (68° to 77°F), that results in a mean kinetic temperature calculated to be not more than 25°C, and that allows for excursions between 15° and 30°C…
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N05AH03 Olanzapine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 January 2012
- Identifiers
- RxCUI 200034, 283639, 312077 +7DailyMed set ID 6077f5c4-01d7-4c1d-97a0-cb859f98ce68, 2cb1bebe-0ced-46d8-bf21-c28a9acc4a15, a4c525da-c2f6-b804-af49-601295922254 +19NDC 67184-0566, 13668-171, 55111-168 +19Application ANDA204319, ANDA091434, ANDA076133 +6
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 19 labelers. The register lists 55 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 67877-177-01 | Ascend LaboratoriesIndia | 1 January 2012 |
| 1000 tablet in 1 bottle | 67877-177-10 | Ascend LaboratoriesIndia | 1 January 2012 |
| 30 tablet in 1 bottle | 67877-177-30 | Ascend LaboratoriesIndia | 1 January 2012 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 67877-177-35 | Ascend LaboratoriesIndia | 1 January 2012 |
| 7 tablet in 1 bottle | 67877-177-37 | Ascend LaboratoriesIndia | 1 January 2012 |
| 3 blister pack in 1 carton / 10 tablet in 1 blister pack | 67877-177-85 | Ascend LaboratoriesIndia | 1 January 2012 |
| 100 tablet in 1 bottle | 65862-566-01 | Aurobindo PharmaIndia | 23 April 2012 |
| 500 tablet in 1 bottle | 65862-566-05 | Aurobindo PharmaIndia | 23 April 2012 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 65862-566-10 | Aurobindo PharmaIndia | 23 April 2012 |
| 30 tablet in 1 bottle | 65862-566-30 | Aurobindo PharmaIndia | 23 April 2012 |
| 1000 tablet in 1 bottle | 65862-566-99 | Aurobindo PharmaIndia | 23 April 2012 |
| 30 tablet in 1 bottle | 71209-078-01 | Cadila PharmaceuticalsIndia | 13 February 2019 |
| 100 tablet in 1 bottle | 71209-078-05 | Cadila PharmaceuticalsIndia | 4 October 2023 |
| 500 tablet in 1 bottle | 71209-078-10 | Cadila PharmaceuticalsIndia | 4 October 2023 |
| 1000 tablet in 1 bottle | 71209-078-11 | Cadila PharmaceuticalsIndia | 13 February 2019 |
| 100 tablet, film coated in 1 bottle | 55111-168-01 | Dr. Reddy's LaboratoriesIndia | 23 April 2012 |
| 500 tablet, film coated in 1 bottle | 55111-168-05 | Dr. Reddy's LaboratoriesIndia | 23 April 2012 |
| 30 tablet, film coated in 1 bottle | 55111-168-30 | Dr. Reddy's LaboratoriesIndia | 23 April 2012 |
| 60 tablet, film coated in 1 bottle | 55111-168-60 | Dr. Reddy's LaboratoriesIndia | 23 April 2012 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 55111-168-78 | Dr. Reddy's LaboratoriesIndia | 23 April 2012 |
| 30 tablet, film coated in 1 bottle | 33342-072-07 | Macleods PharmaceuticalsIndia | 22 August 2014 |
| 100 tablet, film coated in 1 bottle | 33342-072-11 | Macleods PharmaceuticalsIndia | 22 August 2014 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 33342-072-12 | Macleods PharmaceuticalsIndia | 22 August 2014 |
| 500 tablet, film coated in 1 bottle | 33342-072-15 | Macleods PharmaceuticalsIndia | 22 August 2014 |
| 1000 tablet, film coated in 1 bottle | 33342-072-44 | Macleods PharmaceuticalsIndia | 22 August 2014 |
| 100 tablet in 1 bottle | 13668-171-01 | Torrent PharmaceuticalsIndia | 28 February 2026 |
| 500 tablet in 1 bottle | 13668-171-05 | Torrent PharmaceuticalsIndia | 28 February 2026 |
| 1000 tablet in 1 bottle | 13668-171-10 | Torrent PharmaceuticalsIndia | 28 February 2026 |
| 30 tablet in 1 bottle | 13668-171-30 | Torrent PharmaceuticalsIndia | 28 February 2026 |
| 60 tablet in 1 bottle | 13668-171-60 | Torrent PharmaceuticalsIndia | 28 February 2026 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 60505-3140-0 | Apotex | 23 April 2012 |
| 30 tablet, film coated in 1 bottle | 60505-3140-3 | Apotex | 23 April 2012 |
| 1000 tablet, film coated in 1 bottle | 60505-3140-8 | Apotex | 23 April 2012 |
| 30 tablet in 1 bottle, plastic | 72303-0840-1 | HEC Pharm | 30 November 2018 |
| 100 tablet in 1 bottle | 72241-056-04 | Modavar Pharmaceuticals | 17 January 2024 |
| 500 tablet in 1 bottle | 72241-056-10 | Modavar Pharmaceuticals | 17 January 2024 |
| 1000 tablet in 1 bottle | 72241-056-11 | Modavar Pharmaceuticals | 17 January 2024 |
| 30 tablet in 1 bottle | 72241-056-22 | Modavar Pharmaceuticals | 17 January 2024 |
| 30 tablet, film coated in 1 blister pack | 67046-0072-3 | Coupler | 19 June 2026 |
| 30 tablet, film coated in 1 blister pack | 67046-0524-3 | Coupler | 13 May 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Olanzapine 20 mg tablet.
Other strengths and forms of Olanzapine
Clinical summary
Olanzapine is an atypical antipsychotic indicated for the treatment of schizophrenia, among other approved uses. It is available as tablets, orally disintegrating tablets and powder for injection for intramuscular and subcutaneous use. MedsAcross supplies Olanzapine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about OlanzapineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Zyprexa prescribing information (H2-Pharma) · U.S. National Library of Medicine, DailyMed
- Zypadhera: European public assessment report (EPAR) · European Medicines Agency
- Zyprexa Velotab: European public assessment report (EPAR) · European Medicines Agency
Need Olanzapine 20 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.